Trial Outcomes & Findings for Mindfulness-based Smoking Cessation Enhanced With Mobile Technology (NCT NCT04965181)
NCT ID: NCT04965181
Last Updated: 2025-12-30
Results Overview
Self-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm
COMPLETED
NA
504 participants
8 weeks after the start of treatment
2025-12-30
Participant Flow
Participant milestones
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
iQuit Mindfully
Participants will receive iQuit Mindfully text messages and nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
Mindfulness-based Addiction Treatment (MBAT)
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
Usual Care
Participants in the usual care condition are provided with nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
141
|
146
|
147
|
70
|
|
Overall Study
COMPLETED
|
122
|
134
|
126
|
61
|
|
Overall Study
NOT COMPLETED
|
19
|
12
|
21
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
Baseline characteristics by cohort
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=141 Participants
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
iQuit Mindfully
n=146 Participants
Participants will receive iQuit Mindfully text messages and nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
Mindfulness-based Addiction Treatment (MBAT)
n=147 Participants
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
Usual Care
n=70 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
|
Total
n=504 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
49.7 years
STANDARD_DEVIATION 12.8 • n=174 Participants
|
49.8 years
STANDARD_DEVIATION 12.3 • n=166 Participants
|
50.3 years
STANDARD_DEVIATION 13.1 • n=167 Participants
|
53.0 years
STANDARD_DEVIATION 12.7 • n=164 Participants
|
50.4 years
STANDARD_DEVIATION 12.7 • n=671 Participants
|
|
Sex: Female, Male
Female
|
57 Participants
n=174 Participants
|
54 Participants
n=166 Participants
|
56 Participants
n=167 Participants
|
32 Participants
n=164 Participants
|
199 Participants
n=671 Participants
|
|
Sex: Female, Male
Male
|
84 Participants
n=174 Participants
|
92 Participants
n=166 Participants
|
91 Participants
n=167 Participants
|
38 Participants
n=164 Participants
|
305 Participants
n=671 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=174 Participants
|
6 Participants
n=166 Participants
|
5 Participants
n=167 Participants
|
2 Participants
n=164 Participants
|
18 Participants
n=671 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
136 Participants
n=174 Participants
|
140 Participants
n=166 Participants
|
142 Participants
n=167 Participants
|
68 Participants
n=164 Participants
|
486 Participants
n=671 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=174 Participants
|
0 Participants
n=166 Participants
|
0 Participants
n=167 Participants
|
0 Participants
n=164 Participants
|
0 Participants
n=671 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=174 Participants
|
0 Participants
n=166 Participants
|
1 Participants
n=167 Participants
|
0 Participants
n=164 Participants
|
1 Participants
n=671 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=174 Participants
|
2 Participants
n=166 Participants
|
4 Participants
n=167 Participants
|
3 Participants
n=164 Participants
|
12 Participants
n=671 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=174 Participants
|
0 Participants
n=166 Participants
|
0 Participants
n=167 Participants
|
0 Participants
n=164 Participants
|
0 Participants
n=671 Participants
|
|
Race (NIH/OMB)
Black or African American
|
94 Participants
n=174 Participants
|
91 Participants
n=166 Participants
|
92 Participants
n=167 Participants
|
48 Participants
n=164 Participants
|
325 Participants
n=671 Participants
|
|
Race (NIH/OMB)
White
|
34 Participants
n=174 Participants
|
35 Participants
n=166 Participants
|
37 Participants
n=167 Participants
|
16 Participants
n=164 Participants
|
122 Participants
n=671 Participants
|
|
Race (NIH/OMB)
More than one race
|
6 Participants
n=174 Participants
|
13 Participants
n=166 Participants
|
6 Participants
n=167 Participants
|
1 Participants
n=164 Participants
|
26 Participants
n=671 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
4 Participants
n=174 Participants
|
5 Participants
n=166 Participants
|
7 Participants
n=167 Participants
|
2 Participants
n=164 Participants
|
18 Participants
n=671 Participants
|
|
Cigarettes smoked per day at baseline
|
14.7 Number of cigarettes per day
STANDARD_DEVIATION 7.3 • n=174 Participants
|
15.4 Number of cigarettes per day
STANDARD_DEVIATION 9.8 • n=166 Participants
|
14.5 Number of cigarettes per day
STANDARD_DEVIATION 7.5 • n=167 Participants
|
13.6 Number of cigarettes per day
STANDARD_DEVIATION 7.6 • n=164 Participants
|
14.7 Number of cigarettes per day
STANDARD_DEVIATION 8.2 • n=671 Participants
|
PRIMARY outcome
Timeframe: 8 weeks after the start of treatmentSelf-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm
Outcome measures
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=93 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
iQuit Mindfully
n=108 Participants
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Mindfulness-based Addiction Treatment (MBAT)
n=101 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Usual Care
n=52 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
|
|---|---|---|---|---|
|
Number of Participants With Confirmed Smoking Abstinence, 8 Weeks
|
13 Participants
|
29 Participants
|
26 Participants
|
12 Participants
|
PRIMARY outcome
Timeframe: 12 weeks after the start of treatmentSelf-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm
Outcome measures
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=107 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
iQuit Mindfully
n=123 Participants
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Mindfulness-based Addiction Treatment (MBAT)
n=110 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Usual Care
n=55 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
|
|---|---|---|---|---|
|
Number of Participants With Confirmed Smoking Abstinence, 12 Weeks
|
17 Participants
|
27 Participants
|
22 Participants
|
9 Participants
|
PRIMARY outcome
Timeframe: 24 weeks after the start of treatmentSelf-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by carbon monoxide \< 6ppm and saliva cotinine \< 20 ng/ml
Outcome measures
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=107 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
iQuit Mindfully
n=124 Participants
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Mindfulness-based Addiction Treatment (MBAT)
n=120 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Usual Care
n=56 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
|
|---|---|---|---|---|
|
Number of Participants With Confirmed Smoking Abstinence, 24 Weeks
|
18 Participants
|
22 Participants
|
16 Participants
|
8 Participants
|
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported frequency of home mindfulness practice (questionnaire; higher frequency means better outcome)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; MAAS ranges 1-6)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; FFMQ-SF ranges 24-120)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported self-compassion (questionnaire; higher frequency means better outcome; SCS-SF ranges 1-5)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported stress (questionnaire; lower scores mean better outcome; PSS ranges 0-40)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported positive and negative emotions (questionnaire; lower scores on PANAS-Negative Affect mean better outcome; higher scores on PANAS-Positive Affect mean better outcome; PANAS-Negative Affect and Positive Affect each range 10-50)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported craving and withdrawal (questionnaire; lower scores mean better outcome; subscale scores for each withdrawal symptom range 0-4)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported nicotine dependence (questionnaire; lower scores mean better outcome; subscale scores for each aspect of dependence range 1-7)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported self-efficacy to abstain from smoking (questionnaire; higher scores mean better outcome; subscale scores for managing positive affect, negative affect, and craving without smoking range 3-15)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatmentSelf-reported perceived social support (questionnaire)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 8 weeks after treatmentFeedback about interventions and perceived benefits (questionnaire; for quantitative questions, higher scores mean better outcome; for questions about helpfulness and recommending to others, scores range 1-10; for perceived benefits of program, scores range 1-5)
Outcome measures
Outcome data not reported
Adverse Events
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
iQuit Mindfully
Mindfulness-based Addiction Treatment (MBAT)
Usual Care
Serious adverse events
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=141 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
iQuit Mindfully
n=146 participants at risk
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Mindfulness-based Addiction Treatment (MBAT)
n=147 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Usual Care
n=70 participants at risk
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
|
|---|---|---|---|---|
|
Psychiatric disorders
Severe disorientation (unrelated to study intervention)
|
0.00%
0/141 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
0.68%
1/146 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
0.00%
0/147 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
0.00%
0/70 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
Other adverse events
| Measure |
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=141 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
iQuit Mindfully
n=146 participants at risk
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Mindfulness-based Addiction Treatment (MBAT)
n=147 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
|
Usual Care
n=70 participants at risk
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
|
|---|---|---|---|---|
|
Product Issues
Mild side effects of nicotine replacement therapy
|
5.0%
7/141 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
8.2%
12/146 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
8.2%
12/147 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
11.4%
8/70 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place